Lead Author: Mold, M et al.
Original date of publication: 03/18/2026
Link: https://pubmed.ncbi.nlm.nih.gov/29413113/
Summary Context
High levels of aluminum in the deceased brains of people who had autism highlights a link to aluminum-containing vaccines which can cross the blood-brain barrier after injection.
Comments
Visit our Re-post guidelines
This review of autopsy information in five deceased people from 15-50 years old who had been diagnosed with autism found 67% of their brain tissue had physiologically significant levels of aluminum, and they were more prevalent in males where most deposits were intracellular. White blood cells in the meninges had extremely high levels of aluminum in them, which is one potential mechanism of transfer to the brain through the lymphatic system.
Abstract or Results, Key Passages
“The pre-eminence of intracellular aluminium associated with non-neuronal cells was a standout observation in autism brain tissue and may offer clues as to both the origin of the brain aluminium as well as a putative role in autism spectrum disorder.”
Keywords: adjuvantsadverse eventsAluminumaluminum saltsautismlupusneurodegenerative diseaserheumatoid arthritisvaccination
Full Author List: Matthew Mold, Dorcas Umar, Andrew King, Christopher Exley
